Sinovac supplier Pharmaniaga Q2 revenue, earnings soar

KUALA LUMPUR: Pharmaniaga Bhd said its revenue soared 82% to RM1.18bil in the second quarter boosted by sales of Sinovac Covid-19 vaccine to the government.

Net profit rose 37% to RM13.7mil in the three-month ended June 30, the company said in a filing with Bursa Malaysia today. Pharmaniaga has declared a second interim dividend of 1.5 sen a share.